221 related articles for article (PubMed ID: 34748320)
1. A Remote Secondary Binding Pocket Promotes Heteromultivalent Targeting of DC-SIGN.
Wawrzinek R; Wamhoff EC; Lefebre J; Rentzsch M; Bachem G; Domeniconi G; Schulze J; Fuchsberger FF; Zhang H; Modenutti C; Schnirch L; Marti MA; Schwardt O; Bräutigam M; Guberman M; Hauck D; Seeberger PH; Seitz O; Titz A; Ernst B; Rademacher C
J Am Chem Soc; 2021 Nov; 143(45):18977-18988. PubMed ID: 34748320
[TBL] [Abstract][Full Text] [Related]
2. Selective targeting of dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN) with mannose-based glycomimetics: synthesis and interaction studies of bis(benzylamide) derivatives of a pseudomannobioside.
Varga N; Sutkeviciute I; Guzzi C; McGeagh J; Petit-Haertlein I; Gugliotta S; Weiser J; Angulo J; Fieschi F; Bernardi A
Chemistry; 2013 Apr; 19(15):4786-97. PubMed ID: 23417900
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis reveals selective recognition of glycans by the dendritic cell receptors DC-SIGN and Langerin.
Holla A; Skerra A
Protein Eng Des Sel; 2011 Sep; 24(9):659-69. PubMed ID: 21540232
[TBL] [Abstract][Full Text] [Related]
4. Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens.
Fehres CM; Kalay H; Bruijns SC; Musaafir SA; Ambrosini M; van Bloois L; van Vliet SJ; Storm G; Garcia-Vallejo JJ; van Kooyk Y
J Control Release; 2015 Apr; 203():67-76. PubMed ID: 25656175
[TBL] [Abstract][Full Text] [Related]
5. Monovalent mannose-based DC-SIGN antagonists: targeting the hydrophobic groove of the receptor.
Tomašić T; Hajšek D; Švajger U; Luzar J; Obermajer N; Petit-Haertlein I; Fieschi F; Anderluh M
Eur J Med Chem; 2014 Mar; 75():308-26. PubMed ID: 24556146
[TBL] [Abstract][Full Text] [Related]
6. Rational-Differential Design of Highly Specific Glycomimetic Ligands: Targeting DC-SIGN and Excluding Langerin Recognition.
Porkolab V; Chabrol E; Varga N; Ordanini S; Sutkevičiu Tė I; Thépaut M; García-Jiménez MJ; Girard E; Nieto PM; Bernardi A; Fieschi F
ACS Chem Biol; 2018 Mar; 13(3):600-608. PubMed ID: 29272097
[TBL] [Abstract][Full Text] [Related]
7. CellFy: A Cell-Based Fragment Screen against C-Type Lectins.
Schulze J; Baukmann H; Wawrzinek R; Fuchsberger FF; Specker E; Aretz J; Nazaré M; Rademacher C
ACS Chem Biol; 2018 Dec; 13(12):3229-3235. PubMed ID: 30480432
[TBL] [Abstract][Full Text] [Related]
8. Identification of the mycobacterial carbohydrate structure that binds the C-type lectins DC-SIGN, L-SIGN and SIGNR1.
Koppel EA; Ludwig IS; Hernandez MS; Lowary TL; Gadikota RR; Tuzikov AB; Vandenbroucke-Grauls CM; van Kooyk Y; Appelmelk BJ; Geijtenbeek TB
Immunobiology; 2004; 209(1-2):117-27. PubMed ID: 15481146
[TBL] [Abstract][Full Text] [Related]
9. Structure of a glycomimetic ligand in the carbohydrate recognition domain of C-type lectin DC-SIGN. Structural requirements for selectivity and ligand design.
Thépaut M; Guzzi C; Sutkeviciute I; Sattin S; Ribeiro-Viana R; Varga N; Chabrol E; Rojo J; Bernardi A; Angulo J; Nieto PM; Fieschi F
J Am Chem Soc; 2013 Feb; 135(7):2518-29. PubMed ID: 23360500
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis of the differences in binding properties of the highly related C-type lectins DC-SIGN and L-SIGN to Lewis X trisaccharide and Schistosoma mansoni egg antigens.
Van Liempt E; Imberty A; Bank CM; Van Vliet SJ; Van Kooyk Y; Geijtenbeek TB; Van Die I
J Biol Chem; 2004 Aug; 279(32):33161-7. PubMed ID: 15184372
[TBL] [Abstract][Full Text] [Related]
11. The Human Glycoprotein Salivary Agglutinin Inhibits the Interaction of DC-SIGN and Langerin with Oral Micro-Organisms.
Boks MA; Gunput ST; Kosten I; Gibbs S; van Vliet SJ; Ligtenberg AJ; van Kooyk Y
J Innate Immun; 2016; 8(4):350-61. PubMed ID: 27082983
[TBL] [Abstract][Full Text] [Related]
12. Glyco-Dendrimers as Intradermal Anti-Tumor Vaccine Targeting Multiple Skin DC Subsets.
Duinkerken S; Horrevorts SK; Kalay H; Ambrosini M; Rutte L; de Gruijl TD; Garcia-Vallejo JJ; van Kooyk Y
Theranostics; 2019; 9(20):5797-5809. PubMed ID: 31534520
[TBL] [Abstract][Full Text] [Related]
13. The carbohydrate recognition domain of Langerin reveals high structural similarity with the one of DC-SIGN but an additional, calcium-independent sugar-binding site.
Chatwell L; Holla A; Kaufer BB; Skerra A
Mol Immunol; 2008 Apr; 45(7):1981-94. PubMed ID: 18061677
[TBL] [Abstract][Full Text] [Related]
14. Glycosylation-dependent interactions of C-type lectin DC-SIGN with colorectal tumor-associated Lewis glycans impair the function and differentiation of monocyte-derived dendritic cells.
Nonaka M; Ma BY; Murai R; Nakamura N; Baba M; Kawasaki N; Hodohara K; Asano S; Kawasaki T
J Immunol; 2008 Mar; 180(5):3347-56. PubMed ID: 18292560
[TBL] [Abstract][Full Text] [Related]
15. Sugar and spice: viral envelope-DC-SIGN interactions in HIV pathogenesis.
Su SV; Gurney KB; Lee B
Curr HIV Res; 2003 Jan; 1(1):87-99. PubMed ID: 15043214
[TBL] [Abstract][Full Text] [Related]
16. Secondary Sites of the C-type Lectin-Like Fold.
Lefèbre J; Falk T; Ning Y; Rademacher C
Chemistry; 2024 May; 30(30):e202400660. PubMed ID: 38527187
[TBL] [Abstract][Full Text] [Related]
17. DC-SIGN mediates binding of dendritic cells to authentic pseudo-LewisY glycolipids of Schistosoma mansoni cercariae, the first parasite-specific ligand of DC-SIGN.
Meyer S; van Liempt E; Imberty A; van Kooyk Y; Geyer H; Geyer R; van Die I
J Biol Chem; 2005 Nov; 280(45):37349-59. PubMed ID: 16155001
[TBL] [Abstract][Full Text] [Related]
18. Second generation of fucose-based DC-SIGN ligands: affinity improvement and specificity versus Langerin.
Andreini M; Doknic D; Sutkeviciute I; Reina JJ; Duan J; Chabrol E; Thepaut M; Moroni E; Doro F; Belvisi L; Weiser J; Rojo J; Fieschi F; Bernardi A
Org Biomol Chem; 2011 Aug; 9(16):5778-86. PubMed ID: 21735039
[TBL] [Abstract][Full Text] [Related]
19. Noncarbohydrate glycomimetics and glycoprotein surrogates as DC-SIGN antagonists and agonists.
Prost LR; Grim JC; Tonelli M; Kiessling LL
ACS Chem Biol; 2012 Sep; 7(9):1603-8. PubMed ID: 22747463
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of several docking tools for docking small molecule ligands to DC-SIGN.
Jug G; Anderluh M; Tomašič T
J Mol Model; 2015 Jun; 21(6):164. PubMed ID: 26040678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
